The role of biochemical and neurohumoral factors in the laboratory evaluation of antiepileptic drugs.
D000109:Acetylcholine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000613:Aminobutyrates / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D004298:Dopamine / Q000008:administration & dosage / Q000378:metabolism*; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates / Q000008:administration & dosage / Q000378:metabolism*; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012640:Seizures / Q000378:metabolism*; D012701:Serotonin / Q000008:administration & dosage / Q000378:metabolism*; D012702:Serotonin Antagonists; D009435:Synaptic Transmission
D000613:Aminobutyrates; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates; D012702:Serotonin Antagonists; D012701:Serotonin; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine